drugset / Trial / NCT00026988

Creatine Therapy for Huntington's Disease

NCT00026988

RandomizedParallel-groupDouble-blindTreatment

Summary

This study, CREST-HD, will examine the safety and tolerability of 8 grams of creatine in subjects affected by Huntington's disease (HD). Biochemistry and neuroimaging will be used to examine the potential effects of creatine on HD.

Timeline

Start
2001-10
Primary completion
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Creatine Other / unclassified 8 g

Indications